Dr. Jean Pape

Early-onset heart failure is alarmingly common in urban Haiti—over 15-fold higher than previously estimated—according to a study conducted by Weill Cornell Medicine researchers in partnership with the Haitian medical organization GHESKIO.

Weill Cornell Medicine has been awarded a five-year, $5 million grant from the National Institutes of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health to establish a new multi-institutional center for tuberculosis (TB) research and training the next generation of TB investigators.

Awards, honors, prizes and achievements for the month of March.

Dr. Jean William “Bill” Pape, the Howard and Carol Holtzmann Professor in Clinical Medicine and the founder and director of GHESKIO in Haiti, has been awarded the inaugural Joan and Sanford I. Weill Exemplary Achievement Award from Weill Cornell Medicine.

Dr. Daniel Fitzgerald, an international leader in infectious diseases, has been named director of the Center for Global Health at Weill Cornell Medicine.

In a major advance in the fight against drug-resistant tuberculosis, GHESKIO, has opened a state-of-the-art hospital in Port-au-Prince, Haiti, to treat patients suffering from the disease.

NIH's $45.7 million grant to Weill Cornell to support the Tuberculosis Research Unit reflects the medical college's distinguished history in TB research.

The NIH has awarded Weill Cornell up to $45.7 million to fund a research collaboration dedicated to stopping tuberculosis from becoming progressively less treatable worldwide.